Francois Roger Michelon insider trades: ENDRA Life Sciences (NDRA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Francois reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 17, 2022 | NDRA | ↑ Buy | 5,100 | $0.19 | $969 | Direct | May 19, 2022 (2d) |
| Dec 4, 2020 | NDRA | ↓ Sell | 71,519 | $0.83 | $59K | Direct | Dec 8, 2020 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Francois Roger Michelon's insider trades
Francois Roger Michelon is Chief Executive Officer at ENDRA Life Sciences (NDRA). Since Dec 4, 2020, Francois has reported 1 open-market purchase worth $969 and 1 sale worth $59K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (9 filings), conversions (3 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NDRA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.